CCR2 and hematologic disorder: Monocyte chemoattractants, such as C-C motif chemokine ligand 2 (CCL2) and its homologous receptor C-C chemokine receptor type 2 (CCR2), are targeted for the treatment of solid tumors and hematological malignancies using monoclonal antibodies and receptor antagonists.